NEW YORK--(BUSINESS WIRE)--
Levi & Korsinsky announces it has commenced an investigation of United Therapeutics Corporation (“United Therapeutics” or the “Company”) (NASDAQ: UTHR) concerning possible violations of federal securities laws.
On July 27, 2017, United Therapeutics disclosed that it has set aside $210 million in connection to a possible settlement with the U.S. Department of Justice whether the company’s contributions to patient-assistance charity groups violate federal laws against kickbacks and false claims. The DOJ previously subpoenaed United Therapeutics for information about its contributions to non-profit organizations that provide financial assistance to patients with out-of-pocket drug costs. The company stated that it expects any settlement would also include a corporate integrity agreement, and the company may incur significant future costs to comply with that agreement. To obtain additional information, go to:
http://www.zlkdocs.com/UTHR-Info-Request-Form-5976
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170728005397/en/
